Company: TDBCP
Filing Date: 2025-03-04
Form Type: 424B3
Source: 0001140361-25-006811
Chunk: 0

Company: TORONTO DOMINION BANK
Filing Date: 2025-03-04
Form: 424B3
Chunk 0
---
Accelerated Return Notes ®“ARNs ®” Linked to One or More Equity Indices or Exchange Traded Funds

| • | Accelerated Return Notes®(”ARNs”) are senior unsecured debt securities issued by The Toronto-Dominion Bank (“TD”). 
 Any payments due on ARNs, including any repayment of principal, will be subject to the credit risk of TD.          |

| • | ARNs do not guarantee the return of principal at maturity, and we will not pay interest on ARNs.  Instead, the return on ARNs will be based on the performance of an underlying “Market Measure,” 
 which will be an equity index (an “Index”), an exchange traded fund (an “Underlying Fund”), or a basket of the foregoing.                                                                         |

| • | ARNs provide an opportunity to earn a multiple (which will be 3 times, unless otherwise set forth in the applicable pricing supplement (which we refer to as a “term sheet”)) of the positive 
 performance of the Market Measure, up to a specified cap (the “Capped Value”), while exposing you to any negative performance of the Market Measure on a 1-to-1 basis.                        |

| • | If the value of the Market Measure increases from its Starting Value to its Ending Value (each as defined below), you will receive at maturity a cash payment per unit (the “Redemption Amount”) that 
 equals the principal amount plus a multiple of that increase, up to the Capped Value.                                                                                                                 |

| • | If the value of the Market Measure decreases from its Starting Value to its Ending Value, you will be subject to 1-to-1 downside exposure to that decrease.  In such case, you will lose some or all of the principal amount of your ARNs. |

| • | This product supplement describes the general terms of ARNs, the risk factors to consider before investing, the general manner in which they may be offered and sold, and other relevant information. |

| • | For each offering of ARNs, we will provide you with a term sheet that will describe the specific terms of that offering, including the specific Market Measure, the Capped Value, and certain risk factors.  The 
 applicable term sheet will identify, if applicable, any additions or changes to the terms specified in this product supplement.                                                                                  |

| • | ARNs will be issued in denominations of whole units.Unless otherwise set forth in the applicable term sheet, each unit will have a principal amount of $10.The applicable